Sterling

Arcturus Therapeutics vs GSK vs Pfizer and 1 More Revenue Comparison

Compare financial metrics side-by-side using real SEC EDGAR data

Arcturus Therapeutics logo
Arcturus Therapeutics
GSK logo
GSK
Pfizer logo
Pfizer
Merck & Co. logo
Merck & Co.

Revenue Comparison

Chart: Revenue Comparison. Values in USD billions. In Q3 2026: Arcturus Therapeutics 0.018, GSK 11.109, Pfizer 16.583, Merck & Co. 18.085.

Latest Quarter Comparison

Table: Latest Quarter Comparison. 15 rows across Metric, Arcturus Therapeutics, GSK, Pfizer, Merck & Co..
MetricArcturus TherapeuticsGSKPfizerMerck & Co.
Market Cap$231.73M$97.38B$159.94B$339.66B
Revenue$18.00M$11.11B$16.58B$18.09B
Cost of Revenue$0$2.84B$4.03B$4.89B
Gross Profit$18.00M$8.27B$12.55B$13.19B
Operating Income$-9.00M$3.21B$3.67B$5.59B
Net Income$-7.00M$1.93B$3.24B$5.07B
R&D Expense$17.00M$2.34B$3.02B$4.54B
Earnings Per Share-$0.26$0.96$0.56$2.04
Gross Margin100.0%74.5%75.7%73.0%
Operating Margin-50.2%28.9%22.1%30.9%
Net Profit Margin-40.5%17.4%19.6%28.0%
Free Cash Flow$-7.00M$3.04B$4.80B$5.52B
Cumulative Free Cash Flow$-461.00M$160.25B$361.51B$255.22B
Operating Cash Flow$-7.00M$3.51B$5.38B$6.56B
Cash & Equivalents$185.00M$3.72B$1.82B$9.55B

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites